Moderna to receive $176 million of your tax dollars to develop bird flu vaccine
And yes — it will be an mRNA vaccine with some warning it will be developed using gain-of-function research
Even as the fallout from the COVID-19 vaccine continues, Moderna has been awarded $176 million by the federal government to develop another mRNA vaccine for today’s viral scare, bird flu.
Last week, federal officials announced that the pharmaceutical giant would be awarded money by way of the Biomedical Advanced Research and Development Authority through the U.S. Department of Health and Human Services.
The purpose of the funds, as LifeSite reported, is to “accelerate” the development of the vaccine.
“Biomedical Advanced Research and Development Authority (BARDA), a military contractor, has already helped develop a bird flu mRNA shot that has been cleared by the FDA, prompted by a bird flu outbreak in U.S. dairy cows. The vaccine development will include a late-stage trial next year if early testing looks promising,” they report, citing the Associated Press.
They note that one of the chief concerns many had surrounding the COVID-19 “vaccine” was its use of mRNA technology which has an “abysmal” track record, as LifeSite describes it.
So, considering the bird flu vaccine will use mRNA technology and gain-of-function research, here’s a major plot twist:
One of the most published cardiologists in history, Peter McCulloch, recently suggested that this could be to blame for bird flu jumping from animals to humans in the first place, calling for a shutdown on gain-of-function labs, and warned that culling animals and creating vaccines would only help the virus to develop into “more resistant strains.”
The powers that be appear to be trying to use the bird flu as another pandemic, and their colors couldn’t be showing more clearly.